Rabies Diagnostics Market Size, Share, Trends, Growth Outlook

Rabies Diagnostics Market is estimated to increase at a growth rate of 4.5% CAGR over the forecast period from 2024 to 2030.

The global Rabies Diagnostics Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Diagnostic Method (Fluorescent Antibody Test, Immunohistochemical test, Amplification methods, Histologic examination, Serology tests), By Technology (ELISA/Immunohistochemistry, Chromatography techniques, PCR, Others).

An introduction to Rabies Diagnostics Market in 2024

In 2024, the rabies diagnostics market is thriving, supported by the global efforts to control and eliminate rabies transmission, advancements in diagnostic testing methods, and the growing demand for rapid and accurate rabies diagnosis in veterinary and public health sectors. Rabies diagnostics encompass a variety of laboratory tests including direct fluorescent antibody tests (dFAT), enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) assays, enabling the detection of rabies virus antigens or nucleic acids in animal tissues, saliva, or cerebrospinal fluid samples. With innovations in assay sensitivity, specificity, and point-of-care testing formats, the market is experiencing rapid expansion and adoption of rabies diagnostics, facilitating timely diagnosis, surveillance, and control measures to prevent human and animal rabies cases worldwide.

Rabies Diagnostics Market Trend: Increasing Adoption of Point-of-Care Testing

A prominent trend in the Rabies Diagnostics Market is the increasing adoption of point-of-care testing solutions for rapid and accurate diagnosis of rabies infections. Point-of-care tests offer advantages such as rapid results, ease of use, and the ability to perform testing outside of traditional laboratory settings, making them ideal for resource-limited settings and areas with high prevalence of rabies. The demand for point-of-care testing is driven by the need for timely diagnosis and prompt initiation of post-exposure prophylaxis to prevent the spread of rabies in both humans and animals.

Rabies Diagnostics Market Driver: Rising Incidence of Rabies Cases Worldwide

The primary driver of the Rabies Diagnostics Market is the rising incidence of rabies cases worldwide, particularly in regions with inadequate access to vaccination and healthcare infrastructure. Rabies is a deadly viral disease transmitted through the bite of infected animals, such as dogs, bats, and other mammals. The increasing population of stray dogs, urbanization, and lack of awareness about rabies prevention contribute to the high incidence of rabies in many parts of the world. As a result, there is a growing demand for reliable and accurate diagnostic tests to facilitate early detection and management of rabies cases.

Rabies Diagnostics Market Opportunity: Development of Novel Diagnostic Technologies

An opportunity within the Rabies Diagnostics Market lies in the development of novel diagnostic technologies that offer improved sensitivity, specificity, and affordability compared to existing methods. Emerging technologies such as nucleic acid amplification tests (NAATs), rapid immunodiagnostic assays, and advanced imaging techniques hold promise for enhancing the accuracy and efficiency of rabies diagnosis. Additionally, there is a need for diagnostic tests that can differentiate between different strains of the rabies virus and detect early signs of infection to guide appropriate treatment decisions. By investing in research and development initiatives focused on innovation, manufacturers can capitalize on this opportunity to address unmet needs in the market and gain a competitive edge.

Rabies Diagnostics Market Market Segmentation

By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Rabies Diagnostics Market Companies

Abbexa Ltd
Aviva Systems Biology Corp
Bio-Rad Laboratories Inc
Creative Diagnostics.
Demeditec Diagnostics GmbH
Express Biotech International
Merck KGaA
MyBioSource
Norgen Biotek Corp

Reasons to Buy the Rabies Diagnostics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Rabies Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Rabies Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Rabies Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Rabies Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Rabies Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Rabies Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Rabies Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Rabies Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Rabies Diagnostics Industry
4.2 Key Market Trends in Rabies Diagnostics Industry
4.3 Potential Opportunities in Rabies Diagnostics Industry
4.4 Key Challenges in Rabies Diagnostics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Rabies Diagnostics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Rabies Diagnostics Market Outlook by Segments
7.1 Rabies Diagnostics Market Outlook by Segments, $ Million, 2021- 2030
By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

8 North America Rabies Diagnostics Market Analysis and Outlook To 2030
8.1 Introduction to North America Rabies Diagnostics Markets in 2024
8.2 North America Rabies Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Rabies Diagnostics Market size Outlook by Segments, 2021-2030
By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

9 Europe Rabies Diagnostics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Rabies Diagnostics Markets in 2024
9.2 Europe Rabies Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Rabies Diagnostics Market Size Outlook by Segments, 2021-2030
By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

10 Asia Pacific Rabies Diagnostics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Rabies Diagnostics Markets in 2024
10.2 Asia Pacific Rabies Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Rabies Diagnostics Market size Outlook by Segments, 2021-2030
By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

11 South America Rabies Diagnostics Market Analysis and Outlook To 2030
11.1 Introduction to South America Rabies Diagnostics Markets in 2024
11.2 South America Rabies Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Rabies Diagnostics Market size Outlook by Segments, 2021-2030
By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

12 Middle East and Africa Rabies Diagnostics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Rabies Diagnostics Markets in 2024
12.2 Middle East and Africa Rabies Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Rabies Diagnostics Market size Outlook by Segments, 2021-2030
By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbexa Ltd
Aviva Systems Biology Corp
Bio-Rad Laboratories Inc
Creative Diagnostics.
Demeditec Diagnostics GmbH
Express Biotech International
Merck KGaA
MyBioSource
Norgen Biotek Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Diagnostic Method
Fluorescent Antibody Test
Immunohistochemical test
Amplification methods
Histologic examination
Serology tests
By Technology
ELISA/Immunohistochemistry
Chromatography techniques
PCR
Others